New combo therapy aims to shrink tough rectal tumors before surgery
NCT ID NCT06577194
Summary
This study is testing a multi-step treatment plan for people with locally advanced rectal cancer, aiming to shrink tumors before surgery. It combines a short course of radiation with two immunotherapy drugs (PD-1 antibody and IL-2) and a chemotherapy regimen (CAPOX). The main goal is to see how many patients achieve a complete disappearance of their cancer with this approach before undergoing an operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jiangsu Province Hospital
RECRUITINGNanjing, Jiangsu, 210000, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.